The estimated Net Worth of Andrew Satlin is at least $1.71 Million dollars as of 8 January 2020. Andrew Satlin owns over 22,911 units of Intra-Cellular Therapies Inc stock worth over $1,711,910 and over the last 7 years Andrew sold ITCI stock worth over $0.
Andrew has made over 1 trades of the Intra-Cellular Therapies Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Andrew exercised 22,911 units of ITCI stock worth $1,711,910 on 8 January 2020.
The largest trade Andrew's ever made was exercising 22,911 units of Intra-Cellular Therapies Inc stock on 8 January 2020 worth over $1,711,910. On average, Andrew trades about 5,728 units every 0 days since 2017. As of 8 January 2020 Andrew still owns at least 22,911 units of Intra-Cellular Therapies Inc stock.
You can see the complete history of Andrew Satlin stock trades at the bottom of the page.
Andrew's mailing address filed with the SEC is C/O INTRA-CELLULAR THERAPIES, INC., 430 EAST 29TH STREET, NEW YORK, NY, 10016.
Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over $77,703,646 worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth $52,322,638 . The most active insiders traders include Rory B Riggs, Joel S Marcus, and Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,787,280. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth $891,100.
intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: